Clinical Trial Update: High Dose Omeprazole in Patients With Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating high-dose omeprazole in patients with exocrine pancreatic cancer; the study is currently in the recruitment phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: University of Oklahoma | Conditions: Exocrine Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING